WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

PRIMARY ANTI-PHOSPHOLIPID SYNDROME (APLS): A CASE REPORT

Nauman Ismat Butt*, Fahmina Ashfaq, Farhan Mustafa, Bilal Rasheed Khan and Aniqa Anser

ABSTRACT

Anti-Phospholipid Syndrome (APLS) is manifested by recurrent arterial or venous thrombosis and obstetric complications in the presence of Anti-Phospholipid antibodies. The current case is of a 33-year old lady who presented with a second episode of Deep Vein Thrombosis of the left lower limb diagnosed by Doppler ultrasound showing thrombosis of left common femoral and politeal vein. She had been fully mobile, not taking any contraceptive pill and had no recent pregnancy. The first episode of Deep Vein Thrombosis involved bilateral lower limbs, occurring 1 year ago during her post-partum phase and was treated with Rivaroxaban for 3 months. There was a significant history of recurrent abortions over last 12 years, 2 abortions in the third trimester and 5 in first trimester. On investigation, she had thrombocytopenia and prolonged APTT with positive Lupus Anticoagulant and positive Anti-Cardiolipin antibodies. She was diagnosed as having Primary Anti-phospholipid Syndrome and was started on Warfarin with a target INR of 2-3.

Keywords: Primary Anti-phospholipid Syndrome, Recurrent Abortions, Deep Vein Thrombosis, Lupus Anticoagulant, Warfarin.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More